The	the	O	O	O	O
epidemiology	epidemiology	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
acute	acute	O	O	O	O
flank	flank	O	DISEASE	OTHERS	I
pain	pain	O	DISEASE	OTHERS	I
syndrome	syndrome	O	O	O	O
from	from	O	O	O	O
suprofen	suprofen	O	O	OTHERS	I
.	.	O	O	O	O

Suprofen	suprofen	O	O	OTHERS	I
,	,	O	O	O	O
a	a	O	O	O	O
new	new	O	O	O	O
nonsteroidal	nonsteroidal	O	O	O	O
anti-inflammatory	anti-inflammatory	O	O	O	O
drug	drug	O	O	O	O
,	,	O	O	O	O
was	was	O	O	O	O
marketed	marketed	O	O	O	O
in	in	O	O	O	O
early	early	O	O	O	O
1986	1986	O	O	O	O
as	as	O	O	O	O
an	an	O	O	O	O
analgesic	analgesic	O	O	O	O
agent	agent	O	O	O	O
.	.	O	O	O	O

Until	until	O	O	O	O
physicians	physicians	O	O	O	O
began	began	O	O	O	O
reporting	reporting	O	O	O	O
an	an	O	O	O	O
unusual	unusual	O	O	O	O
acute	acute	O	O	O	O
flank	flank	O	DISEASE	OTHERS	I
pain	pain	O	DISEASE	OTHERS	I
syndrome	syndrome	O	O	O	O
to	to	O	O	O	O
the	the	O	O	O	O
spontaneous	spontaneous	O	O	O	O
reporting	reporting	O	O	O	O
system	system	O	O	O	O
,	,	O	O	O	O
700,000	700,000	O	O	O	O
persons	persons	O	O	O	O
used	used	O	O	O	O
the	the	O	O	O	O
drug	drug	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
United	united	O	O	O	O
States	states	O	O	O	O
.	.	O	O	O	O
Through	through	O	O	O	O
August	august	O	O	O	O
1986	1986	O	O	O	O
,	,	O	O	O	O
a	a	O	O	O	O
total	total	O	O	O	O
of	of	O	O	O	O
163	163	O	O	O	O
cases	cases	O	O	O	O
of	of	O	O	O	O
this	this	O	O	O	O
syndrome	syndrome	O	O	O	O
were	were	O	O	O	O
reported	reported	O	O	O	O
.	.	O	O	O	O

To	to	O	O	O	O
elucidate	elucidate	O	O	O	O
the	the	O	O	O	O
epidemiology	epidemiology	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
syndrome	syndrome	O	O	O	O
,	,	O	O	O	O
a	a	O	O	O	O
case-control	case-control	O	O	O	O
study	study	O	O	O	O
was	was	O	O	O	O
performed	performed	O	O	O	O
,	,	O	O	O	O
comparing	comparing	O	O	O	O
62	62	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
case	case	O	O	O	O
patients	patients	O	O	O	O
who	who	O	O	O	O
had	had	O	O	O	O
been	been	O	O	O	O
reported	reported	O	O	O	O
to	to	O	O	O	O
the	the	O	O	O	O
spontaneous	spontaneous	O	O	O	O
reporting	reporting	O	O	O	O
system	system	O	O	O	O
to	to	O	O	O	O
185	185	O	O	O	O
suprofen-exposed	suprofen-exposed	O	O	O	O
control	control	O	O	O	O
subjects	subjects	O	O	O	O
who	who	O	O	O	O
did	did	O	O	O	O
not	not	O	O	O	O
have	have	O	O	O	O
the	the	O	O	O	O
syndrome	syndrome	O	O	O	O
.	.	O	O	O	O

Case	case	O	O	O	O
patients	patients	O	O	O	O
were	were	O	O	O	O
more	more	O	O	O	O
likely	likely	O	O	O	O
to	to	O	O	O	O
be	be	O	O	O	O
men	men	O	O	O	O
(	(	O	O	O	O
odds	odds	O	O	O	O
ratio	ratio	O	O	O	O
,	,	O	O	O	O
3.8	3.8	O	O	O	O
;	;	O	O	O	O
95	95	O	O	O	O
%	%	O	O	O	O
confidence	confidence	O	O	O	O
interval	interval	O	O	O	O
,	,	O	O	O	O
1.2	1.2	O	O	O	O
-	-	O	O	O	O
12.1	12.1	O	O	O	O
)	)	O	O	O	O
,	,	O	O	O	O
suffer	suffer	O	O	O	O
from	from	O	O	O	O
hay	hay	O	O	OTHERS	I
fever	fever	O	DISEASE	OTHERS	I
and	and	O	O	O	O
asthma	asthma	O	O	OTHERS	I
(	(	O	O	O	O
odds	odds	O	O	O	O
ratio	ratio	O	O	O	O
,	,	O	O	O	O
3.4	3.4	O	O	O	O
;	;	O	O	O	O
95	95	O	O	O	O
%	%	O	O	O	O
confidence	confidence	O	O	O	O
interval	interval	O	O	O	O
,	,	O	O	O	O
1.0	1.0	O	O	O	O
-	-	O	O	O	O
11.9	11.9	O	O	O	O
)	)	O	O	O	O
;	;	O	O	O	O
to	to	O	O	O	O
participate	participate	O	O	O	O
in	in	O	O	O	O
regular	regular	O	O	O	O
exercise	exercise	O	O	O	O
(	(	O	O	O	O
odds	odds	O	O	O	O
ratio	ratio	O	O	O	O
,	,	O	O	O	O
5.9	5.9	O	O	O	O
;	;	O	O	O	O
95	95	O	O	O	O
%	%	O	O	O	O
confidence	confidence	O	O	O	O
interval	interval	O	O	O	O
,	,	O	O	O	O
1.1	1.1	O	O	O	O
-	-	O	O	O	O
30.7	30.7	O	O	O	O
)	)	O	O	O	O
,	,	O	O	O	O
especially	especially	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
use	use	O	O	O	O
of	of	O	O	O	O
Nautilus	nautilus	O	O	O	O
equipment	equipment	O	O	O	O
(	(	O	O	O	O
p	p	O	O	OTHERS	I
=	=	O	O	O	O
0.02	0.02	O	O	O	O
)	)	O	O	O	O
;	;	O	O	O	O
and	and	O	O	O	O
to	to	O	O	O	O
use	use	O	O	O	O
alcohol	alcohol	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
odds	odds	O	O	O	O
ratio	ratio	O	O	O	O
,	,	O	O	O	O
4.4	4.4	O	O	O	O
;	;	O	O	O	O
95	95	O	O	O	O
%	%	O	O	O	O
confidence	confidence	O	O	O	O
interval	interval	O	O	O	O
,	,	O	O	O	O
1.1	1.1	O	O	O	O
-	-	O	O	O	O
17.5	17.5	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

Possible	possible	O	O	O	O
risk	risk	O	O	O	O
factors	factors	O	O	O	O
included	included	O	O	O	O
young	young	O	O	O	O
age	age	O	O	O	O
,	,	O	O	O	O
concurrent	concurrent	O	O	O	O
use	use	O	O	O	O
of	of	O	O	O	O
other	other	O	O	O	O
analgesic	analgesic	O	O	O	O
agents	agents	O	O	O	O
(	(	O	O	O	O
especially	especially	O	O	O	O
ibuprofen	ibuprofen	CHEMICALS	O	OTHERS	I
)	)	O	O	O	O
,	,	O	O	O	O
preexisting	preexisting	O	O	O	O
renal	renal	O	O	OTHERS	I
disease	disease	O	O	OTHERS	I
,	,	O	O	O	O
a	a	O	O	O	O
history	history	O	O	O	O
of	of	O	O	O	O
kidney	kidney	O	O	OTHERS	I
stones	stones	O	O	OTHERS	I
,	,	O	O	O	O
a	a	O	O	O	O
history	history	O	O	O	O
of	of	O	O	O	O
gout	gout	O	O	OTHERS	I
,	,	O	O	O	O
a	a	O	O	O	O
recent	recent	O	O	O	O
increase	increase	O	O	O	O
in	in	O	O	O	O
activity	activity	O	O	O	O
,	,	O	O	O	O
a	a	O	O	O	O
recent	recent	O	O	O	O
increase	increase	O	O	O	O
in	in	O	O	O	O
sun	sun	O	O	O	O
exposure	exposure	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
residence	residence	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
Sunbelt	sunbelt	O	O	O	O
.	.	O	O	O	O

These	these	O	O	O	O
were	were	O	O	O	O
findings	findings	O	O	O	O
that	that	O	O	O	O
were	were	O	O	O	O
suggestive	suggestive	O	O	O	O
but	but	O	O	O	O
did	did	O	O	O	O
not	not	O	O	O	O
reach	reach	O	O	O	O
conventional	conventional	O	O	O	O
statistical	statistical	O	O	O	O
significance	significance	O	O	O	O
.	.	O	O	O	O

These	these	O	O	O	O
findings	findings	O	O	O	O
are	are	O	O	O	O
consistent	consistent	O	O	O	O
with	with	O	O	O	O
the	the	O	O	O	O
postulated	postulated	O	O	O	O
mechanism	mechanism	O	O	O	O
for	for	O	O	O	O
this	this	O	O	O	O
unusual	unusual	O	O	O	O
syndrome	syndrome	O	O	O	O
:	:	O	O	O	O
acute	acute	O	O	O	O
diffuse	diffuse	O	O	O	O
crystallization	crystallization	O	O	O	O
of	of	O	O	O	O
uric	uric	CHEMICALS	O	OTHERS	I
acid	acid	CHEMICALS	O	OTHERS	I
in	in	O	O	O	O
renal	renal	O	O	O	O
tubules	tubules	O	O	O	O
.	.	O	O	O	O

